These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Effect of TRH and its analog DN-1417 on anoxia-induced amnesia in mice]. Yamazaki N; Shintani M; Saji Y; Nagawa Y Yakubutsu Seishin Kodo; 1985 May; 5(1):1-9. PubMed ID: 2996254 [TBL] [Abstract][Full Text] [Related]
23. [Montirelin hydrate (NS-3), a TRH analog, improved the disturbance of consciousness caused by head concussion and pentobarbital in mice]. Mushiroi T; Shibahara R; Tamura M; Shimizu T; Itoh Y; Ukai Y; Yoshikuni Y; Kimura K Nihon Yakurigaku Zasshi; 1996 May; 107(5):237-45. PubMed ID: 8690305 [TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships of TRH analogs in rat spinal cord injury. Faden AI; Sacksen I; Noble LJ Brain Res; 1988 May; 448(2):287-93. PubMed ID: 3132308 [TBL] [Abstract][Full Text] [Related]
25. Behavioral changes induced by the thyrotropin-releasing hormone analogue, RGH 2202. Drago F; Grassi M; Valerio C; Coppi G; Lauria N; Nicotra GC; Raffaele R Peptides; 1991; 12(6):1309-13. PubMed ID: 1815218 [TBL] [Abstract][Full Text] [Related]
26. ECT and TRH: cholinergic involvement in a cognitive deficit state. Khan A; Mirolo MH; Lai H; Claypoole K; Bierut L; Malik R; Bhang J Psychopharmacol Bull; 1993; 29(3):345-52. PubMed ID: 8121962 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats. Itoh Y; Yamazaki A; Ukai Y; Yoshikuni Y; Kimura K Pharmacol Toxicol; 1996 Jun; 78(6):421-8. PubMed ID: 8829205 [TBL] [Abstract][Full Text] [Related]
28. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals. Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282 [TBL] [Abstract][Full Text] [Related]
29. Differential affinities of TRH analogs at the mammalian spinal cord TRH receptor: implications for therapy in spinal injuries. Sharif NA; To Z; Michel AD; Whiting RL Neurosci Lett; 1989 Sep; 104(1-2):183-8. PubMed ID: 2554219 [TBL] [Abstract][Full Text] [Related]
30. TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats. Kinoshita K; Watanabe Y; Yamamura M; Matsuoka Y Eur J Pharmacol; 1998 Feb; 343(2-3):129-33. PubMed ID: 9570459 [TBL] [Abstract][Full Text] [Related]
32. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog. Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872 [TBL] [Abstract][Full Text] [Related]
33. Effects of bifemelane hydrochloride (MCI-2016) on experimental amnesia (passive avoidance failure) in rodents. Tobe A; Yamaguchi T; Nagai R; Egawa M Jpn J Pharmacol; 1985 Oct; 39(2):153-61. PubMed ID: 4087564 [TBL] [Abstract][Full Text] [Related]
34. Electroconvulsive seizures modulate levels of thyrotropin releasing hormone and related peptides in rat hypothalamus, cingulate and lateral cerebellum. Pekary AE; Meyerhoff JL; Sattin A Brain Res; 2000 Nov; 884(1--2):174-83. PubMed ID: 11082499 [TBL] [Abstract][Full Text] [Related]
35. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats. Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129 [TBL] [Abstract][Full Text] [Related]
36. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats. Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 3rd communication: identification of metabolites in rat urine. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):127-33. PubMed ID: 8720300 [TBL] [Abstract][Full Text] [Related]
38. Effects of TA-0910, an orally active TRH analog, on the spinal reflex in spinal rats. Kinoshita K; Nagao T; Ono H Neuropharmacology; 1994 Oct; 33(10):1183-8. PubMed ID: 7862253 [TBL] [Abstract][Full Text] [Related]
39. [The effects of acute administration of thyrotropin-releasing hormone on conditioned active avoidance learning and passive avoidance learning in rats (author's transl)]. Hayashi T Nihon Naibunpi Gakkai Zasshi; 1981 May; 57(5):747-61. PubMed ID: 6793411 [TBL] [Abstract][Full Text] [Related]
40. Antiepileptic effects of CNK-602A, a novel thyrotropin-releasing hormone analog, on absence-like and tonic seizures of spontaneously epileptic rats. Renming X; Ishihara K; Sasa M; Ujihara H; Momiyama T; Fujita Y; Todo N; Serikawa T; Yamada J; Takaori S Eur J Pharmacol; 1992 Nov; 223(2-3):185-92. PubMed ID: 1478266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]